147 related articles for article (PubMed ID: 30837363)
1. G-quadruplex forming region within WT1 promoter is selectively targeted by daunorubicin and mitoxantrone: A possible mechanism for anti-leukemic effect of drugs.
Zidanloo SG; Colagar AH; Ayatollahi H; Bagheryan Z
J Biosci; 2019 Mar; 44(1):. PubMed ID: 30837363
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of the WT1 gene expression via TMPyP4 stabilization of promoter G-quadruplexes in leukemia cells.
Zidanloo SG; Hosseinzadeh Colagar A; Ayatollahi H; Raoof JB
Tumour Biol; 2016 Jul; 37(7):9967-77. PubMed ID: 26815508
[TBL] [Abstract][Full Text] [Related]
3. Anti-apoptotic quinolinate phosphoribosyltransferase (QPRT) is a target gene of Wilms' tumor gene 1 (WT1) protein in leukemic cells.
Ullmark T; Montano G; Järvstråt L; Jernmark Nilsson H; Håkansson E; Drott K; Nilsson B; Vidovic K; Gullberg U
Biochem Biophys Res Commun; 2017 Jan; 482(4):802-807. PubMed ID: 27889611
[TBL] [Abstract][Full Text] [Related]
4. The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation-induced cell death in leukemic T cells.
Bourkoula K; Englert C; Giaisi M; Köhler R; Krammer PH; Li-Weber M
Int J Cancer; 2014 Jan; 134(2):291-300. PubMed ID: 23832418
[TBL] [Abstract][Full Text] [Related]
5. Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants.
Siehl JM; Reinwald M; Heufelder K; Menssen HD; Keilholz U; Thiel E
Ann Hematol; 2004 Dec; 83(12):745-50. PubMed ID: 15340762
[TBL] [Abstract][Full Text] [Related]
6. Role of the Wilms' tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanisms.
Li Y; Wang J; Li X; Jia Y; Huai L; He K; Yu P; Wang M; Xing H; Rao Q; Tian Z; Tang K; Wang J; Mi Y
Oncol Rep; 2014 Dec; 32(6):2680-6. PubMed ID: 25310451
[TBL] [Abstract][Full Text] [Related]
7. Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis.
Galimberti S; Guerrini F; Carulli G; Fazzi R; Palumbo GA; Morabito F; Petrini M
Eur J Haematol; 2004 Jan; 72(1):45-51. PubMed ID: 14962262
[TBL] [Abstract][Full Text] [Related]
8. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
9. Selective recognition of oncogene promoter G-quadruplexes by Mg2+.
Yan YY; Lin J; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
Biochem Biophys Res Commun; 2010 Nov; 402(4):614-8. PubMed ID: 20971074
[TBL] [Abstract][Full Text] [Related]
10. Blocking the binding of WT1 to
Xiong YX; Chen AC; Yao PF; Zeng DY; Lu YJ; Tan JH; Huang ZS; Ou TM
Biochem Biophys Rep; 2016 Mar; 5():346-352. PubMed ID: 28955841
[TBL] [Abstract][Full Text] [Related]
11. WT1 Expression in Adult Acute Myeloid Leukemia: Assessing its Presence, Magnitude and Temporal Changes as Prognostic Factors.
Ujj Z; Buglyó G; Udvardy M; Beyer D; Vargha G; Biró S; Rejtő L
Pathol Oncol Res; 2016 Jan; 22(1):217-21. PubMed ID: 26531831
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of WT1 and its target gene IRF8 expression in acute myeloid leukemia and their significance.
Zhang Q; Zhang Q; Li Q; Liu B; Wang Y; Lin D; Zhou C; Li W; Tang K; Tian Z; Wang M; Wang J; Mi Y
Int J Lab Hematol; 2015 Aug; 37(4):e67-71. PubMed ID: 25387409
[No Abstract] [Full Text] [Related]
13. A comparison of in vitro sensitivity of acute myeloid leukemia precursors to mitoxantrone, 4'deoxydoxorubicin, 4-demethoxydaunorubicin and daunorubicin.
Schölzel C; van Putten W; Löwenberg B
Leuk Res; 1986; 10(12):1455-9. PubMed ID: 3467144
[TBL] [Abstract][Full Text] [Related]
14. 9-N-Substituted berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc.
Ma Y; Ou TM; Hou JQ; Lu YJ; Tan JH; Gu LQ; Huang ZS
Bioorg Med Chem; 2008 Aug; 16(16):7582-91. PubMed ID: 18674916
[TBL] [Abstract][Full Text] [Related]
15. In vitro leukemic cell differentiation and WT1 gene expression.
Hernandez-Caballero E; Mayani H; Montesinos JJ; Arenas D; Salamanca F; Peñaloza R
Leuk Res; 2007 Mar; 31(3):395-7. PubMed ID: 16828156
[TBL] [Abstract][Full Text] [Related]
16. Detectable Wilms' tumor-1 transcription at treatment completion is associated with poor prognosis of acute myeloid leukemia: a single institution's experience.
Yamauchi T; Negoro E; Lee S; Takai M; Matsuda Y; Takagi K; Kishi S; Tai K; Hosono N; Tasaki T; Ikegaya S; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
Anticancer Res; 2013 Aug; 33(8):3335-40. PubMed ID: 23898100
[TBL] [Abstract][Full Text] [Related]
17. WT1 inhibits AML cell proliferation in a p53-dependent manner.
Yao Y; Chai X; Gong C; Zou L
Cell Cycle; 2021 Aug; 20(16):1552-1560. PubMed ID: 34288813
[TBL] [Abstract][Full Text] [Related]
18. Use of Wilms Tumor 1 Gene Expression as a Reliable Marker for Prognosis and Minimal Residual Disease Monitoring in Acute Myeloid Leukemia With Normal Karyotype Patients.
Marjanovic I; Karan-Djurasevic T; Ugrin M; Virijevic M; Vidovic A; Tomin D; Suvajdzic Vukovic N; Pavlovic S; Tosic N
Clin Lymphoma Myeloma Leuk; 2017 May; 17(5):312-319. PubMed ID: 28163010
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of The Wilms' Tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemia.
Petiti J; Rosso V; Lo Iacono M; Calabrese C; Signorino E; Gaidano V; Berger M; Saglio G; Cilloni D
Leuk Res; 2018 Apr; 67():6-11. PubMed ID: 29407184
[TBL] [Abstract][Full Text] [Related]
20. Effects of bufalin on up-regulating methylation of Wilm's tumor 1 gene in human erythroid leukemic cells.
Wang LP; Zhao YN; Sun X; Gao RL
Chin J Integr Med; 2017 Apr; 23(4):288-294. PubMed ID: 28364352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]